Valuation (71%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 13.78 | N/A |
| PEG Ratio (TTM) | 36.10 | N/A |
| P/S Ratio (TTM) | 1.84 | N/A |
| P/B Ratio (TTM) | 5.39 | N/A |
| P/FCF Ratio (TTM) | 15.93 | N/A |
| Price to 5YR AVG Earnings Ratio | 15.26 | N/A |
| Price to 5YR AVG FCF Ratio | 12.21 | N/A |
Profitability (75%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 9.40% | N/A |
| ROE (TTM) | 41.25% | N/A |
| Net Profit Margin (TTM) | 13.54% | N/A |
| ROIC 5YR AVG | 24.05% | N/A |
Growth (45%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 7.46% | 3.89% | 2.27% |
| Revenue | -0.32% | 4.04% | 3.16% |
| Net Income | 7.06% | 4.11% | 0.69% |
| Cash Flow | 23.85% | 8.63% | 6.86% |
Health (42%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.64 | N/A |
| Quick Ratio (TTM) | 1.23 | N/A |
| D/E Ratio (TTM) | 2.14 | N/A |
| Interest Coverage (TTM) | 6.74 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 2.75 | N/A |
| LTL to 5YR AVG FCF | 4.94 | N/A |
| Shares Outstanding Growth 5YR AVG | -1.60% | N/A |